Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) has received a consensus rating of "Moderate Buy" from analysts, with one hold recommendation and five buy recommendations among the six research firms covering the company.
• Wells Fargo recently reduced their target price for KMTS from $28.00 to $27.00 while maintaining an "overweight" rating on the stock.
• The company's stock opened at $18.00, with a 52-week range between a low of $13.25 and a high of $26.15, while showing strong liquidity with a current ratio of 6.72.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) has received a consensus rating of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $27.3333.

Separately, Wells Fargo & Company decreased their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 17th.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in KMTS. Quarry LP purchased a new stake in Kestra Medical Technologies in the first quarter valued at about $33,000. Police & Firemen s Retirement System of New Jersey acquired a new position in shares of Kestra Medical Technologies during the second quarter valued at about $54,000. Russell Investments Group Ltd. raised its position in shares of Kestra Medical Technologies by 26.5% in the 2nd quarter. Russell Investments Group Ltd. now owns 23,202 shares of the company's stock valued at $385,000 after purchasing an additional 4,859 shares during the last quarter. New York State Common Retirement Fund acquired a new stake in Kestra Medical Technologies in the 2nd quarter worth approximately $93,000. Finally, Virtu Financial LLC purchased a new stake in Kestra Medical Technologies during the 1st quarter worth approximately $210,000.

Kestra Medical Technologies Stock Performance

NASDAQ:KMTS opened at $18.00 on Thursday. The firm has a 50-day moving average price of $16.17. The company has a current ratio of 6.72, a quick ratio of 6.72 and a debt-to-equity ratio of 0.20. Kestra Medical Technologies has a fifty-two week low of $13.25 and a fifty-two week high of $26.15.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.